SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-034502
Filing Date
2021-03-10
Accepted
2021-03-10 16:44:50
Documents
12
Period of Report
2021-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219243d1_8k.htm   iXBRL 8-K 26984
  Complete submission text file 0001104659-21-034502.txt   201097

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20210309.xsd EX-101.SCH 3175
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20210309_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20210309_pre.xml EX-101.PRE 22703
5 EXTRACTED XBRL INSTANCE DOCUMENT tm219243d1_8k_htm.xml XML 3608
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 21730413
SIC: 2834 Pharmaceutical Preparations